Authors

Clearing the Air: The Influence of Vaping on Smoking Cessation

Pharmacists can help address nicotine addiction by recommending FDA-approved smoking cessation methods and educating on the risks associated with electronic cigarette use.

McKesson ideaShare 2025: Micro-Access Pharmacies Expand Care Through Innovation, Technology, and Policy

Examining an Important Orphan Disease: Neurotrophic Keratitis/Keratopathy and Its Treatment

NK is a degenerative corneal disease resulting from diminished corneal innervation.

A Hospital’s Outpatient Pharmacies Attempt to Reduce DIR Fees Using Performance Reports

This quality improvement initiative demonstrates that pharmacies were unable to use performance reports provided by the payer to improve performance scores and decrease direct and indirect remuneration (DIR) fees.

DPYD Testing Gains Ground: NCCN Guideline Update Reflects Decades of Work Toward Safer Chemotherapy

The Phase 3 AMPLIFY Trial Assesses a New Treatment Paradigm in Patients With Treatment-Naive CLL

Investigators assessed fixed-duration venetoclax plus acalabrutinib with or without obinutuzumab vs chemoimmunotherapy.

Unlocking PROTACs’ Potential: Overcoming Development Challenges

Proteolysis-targeting chimeras hold enormous potential, but also present significant challenges to drug developers.

Paradoxical Hypotension After Inadvertent Intravenous Administration of Epinephrine

Raising awareness of the potentially fatal cardiovascular complications of epinephrine toxicity.

Omalizumab: An All-in-One Allergy Wonder Drug?

Omalizumab expands its role in allergy management, now FDA-approved for food allergies, showcasing potential for broader applications in allergic rhinitis.

Just Culture Meets AI: How Pharmacists Are Leading Safer Transitions of Care

Enhancing PrEP Utilization Among Transgender Women: A Crucial Role for Pharmacists

Pharmacists can bridge gaps through education, inclusive care, and streamlined access.

Impact of Time to First Epinephrine Administration on Outcomes After In-Hospital Cardiac Arrest With Initial Nonshockable Rhythm

This study found no significant difference in the sustained return of spontaneous circulation or survival to hospital discharge based on the timing of the first epinephrine administration in these patients.

McKesson ideaShare 2025: Pharmacy of the Year Finalist Keri Bates Reflects on Teamwork, Community, and the Road Ahead

Keri Bates, PharmD, shares how the nomination validates years of hard work, highlights the deep relationships built with the community, and inspires continued growth and innovation.

Study Highlights Filgrastim Savings Potential With Biosimilars

OTC Case Studies: Self-Care for Flu

Understand the Inextricable Link Between the Pharmacy Revenue Cycle and 340B

By aligning the pharmacy revenue cycle with the 340B Drug Pricing Program, organizations can maximize revenue capture from medications while ensuring compliance with 340B requirements, leading to enhanced financial performance and improved care for underserved populations.

A Pharmacist’s Guide to Diabetic Ketoacidosis

Diabetic ketoacidosis poses serious risks for patients with diabetes, requiring urgent treatment to prevent life-threatening complications and ensure recovery.

Emerging BCMA-Directed Therapies in Multiple Myeloma: Bispecific Antibodies and CAR T-Cell Therapies

Here is an updated overview of the role of BCMA-directed therapies following the 2024 ASCO Annual Meeting and EHA Congress.

FDA Approves Elinzanetant as First Nonhormonal Therapy for Menopause Vasomotor Symptoms

Elinzanetant, the first FDA-approved nonhormonal treatment for menopause-related hot flashes, offers women a new, effective relief option.

Overcoming Failure as a Recent Pharmacy Graduate

Failing is not final, and it does not define what kind of pharmacist or resident a student can be.

Pharmacists and Providers: Key Collaborators in the Shift Toward Decentralized and Virtual Health Care

Virtual health care enhances patient experiences, integrates complex data, and ensures medication access through provider-pharmacist collaboration.

Designing for Safety: The Pharma Industry’s Role in Preventing Medication Errors

Pharmaceutical companies must consider formulation, packaging, and labeling from the start to minimize errors and protect patients.

Reduced POMP Dosing Shows Comparable Efficacy in ALL Maintenance

Arefa Bacchus, PharmD, shared key insights about the use of POMP therapy in patients with acute lymphoblastic leukemia (ALL).

Combination Therapies and Resistance-Based Approaches Reshape EGFR Care

Mya Tran, PharmD, BCOP, offers insights for navigating the complex treatment landscape for non-small cell lung cancer.

Respiratory Syncytial Virus in Older Adults: Research Insights and Recommendations

Although RSV has long been associated with infants and young children, research demonstrates that it is also a significant health risk for adults over the age of 60.

Revolutionizing Treatment with Bispecific Therapies: Navigating the Challenges Ahead

By decade’s end, approval of additional bispecifics is expected for hematological malignancies, solid tumors, and non-oncology conditions such as inflammatory, autoimmune, neurodegenerative and vascular diseases, and ocular disorders and infections.

A Hospital’s Outpatient Pharmacies Attempt to Reduce DIR Fees Using Performance Reports

This quality improvement initiative demonstrates that pharmacies were unable to use performance reports provided by the payer to improve performance scores and decrease direct and indirect remuneration (DIR) fees.

The Evolving Role of Pharmacovigilance in Digital Therapeutics

Digital therapeutics (DTx), a novel evidence-based software approach, is revolutionizing health care by delivering personalized treatments. Pharmacovigilance ensures DTx safety but faces challenges such as data privacy and standardization.

Exploring the Antidepressant Potential of GLP-1 Receptor Agonists

GLP-1 receptor agonists show promise in alleviating depressive symptoms in patients with type 2 diabetes, offering a potential dual benefit in treatment.

Emerging BCMA-Directed Therapies in Multiple Myeloma: Bispecific Antibodies and CAR T-Cell Therapies

Here is an updated overview of the role of BCMA-directed therapies following the 2024 ASCO Annual Meeting and EHA Congress.